KOTLER KEVIN

CIK 1601692 · View on SEC EDGAR ↗

Portfolio value
$359.0M
#4,657 of 9,443 by 13F value · top 49.3%
Positions
38
As of
Dec. 31, 2025 Data as of Q4 2025
Top 10 holdings weight
92.32%
Top 25 holdings weight
98.88%
Positions above 1%
10
Effective number of positions
2.2

Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)

New positions
38
Increased
0
Decreased
0
Closed
0

Put-notional exposure: 75.0% puts 13F reports option positions at underlying notional value — may include hedges, not necessarily bearish bets

On this page

Sector breakdown

Healthcare
22.6%
Industrials
1.6%
Consumer Discretionary
0.6%
Financials
0.1%
Retail
0.1%
Other/Unmapped
75.1%

Full portfolio 38 positions

Type Streak 8Q trend
SPY SPY $238,672,000 66.48% 350,000 Put option Up ×1
QQQ Invesco QQQ Trust, Series 1 $30,715,500 8.56% 50,000 Put option Up ×1
AVDL Avadel Pharmaceuticals plc - Ordinary Share $18,951,070 5.28% 879,400 Call option Up ×1
AVDL Avadel Pharmaceuticals plc - Ordinary Share $15,085,000 4.20% 700,000 Up ×1
MDWD MediWound Ltd. - Ordinary Shares $6,065,070 1.69% 328,552 Up ×1
AXGN Axogen, Inc. - Common Stock $5,498,640 1.53% 168,000 Up ×1
EVTL Vertical Aerospace Ltd. Ordinary Shares $4,797,000 1.34% 900,000 Up ×1
OSUR OraSure Technologies, Inc. - Common Stock $4,288,240 1.19% 1,772,000 Up ×1
OMER Omeros Corporation - Common Stock $3,794,445 1.06% 218,700 Call option Up ×1
AUPH Aurinia Pharmaceuticals Inc - Common Shares $3,586,294 1.00% 224,846 Up ×1
GLPG Galapagos NV - American Depositary Shares $2,943,000 0.82% 90,000 Up ×1
ANGO AngioDynamics, Inc. - Common Stock $2,737,218 0.76% 213,789 Up ×1
OMER Omeros Corporation - Common Stock $2,232,492 0.62% 129,985 Up ×1
LLY Eli Lilly and Company Common Stock $2,149,360 0.60% 2,000 Up ×1
CERS Cerus Corporation - Common Stock $2,060,000 0.57% 1,000,000 Up ×1
NKE Nike, Inc. Common Stock $2,038,720 0.57% 32,000 Up ×1
TECX Tectonic Therapeutic, Inc. - Common Stock $1,668,800 0.46% 80,000 Up ×1
CLYM Climb Bio, Inc. - Common Stock $1,600,000 0.45% 400,000 Up ×1
TMCI Treace Medical Concepts, Inc. - Common Stock $1,053,500 0.29% 430,000 Up ×1
TLSI TriSalus Life Sciences, Inc. - Common Stock $1,013,496 0.28% 145,200 Up ×1
DXCM DexCom, Inc. - Common Stock $995,550 0.28% 15,000 Up ×1
ACRS Aclaris Therapeutics, Inc. - Common Stock $920,846 0.26% 305,929 Up ×1
VNDA Vanda Pharmaceuticals Inc. - Common Stock $882,000 0.25% 100,000 Up ×1
ALGN Align Technology, Inc. - Common Stock $680,658 0.19% 4,359 Up ×1
OKUR OnKure Therapeutics, Inc. - Class A Common Stock $573,304 0.16% 197,691 Up ×1
NPCE Neuropace, Inc. - Common Stock $467,338 0.13% 30,268 Up ×1
GE GE Aerospace Common Stock $452,188 0.13% 1,468 Up ×1
LUNG Pulmonx Corporation - Common Stock $442,000 0.12% 200,000 Up ×1
PTCT PTC Therapeutics, Inc. - Common Stock $379,800 0.11% 5,000 Up ×1
DY Dycom Industries, Inc. Common Stock $355,133 0.10% 1,051 Up ×1
IART Integra LifeSciences Holdings Corporation - Common Stock $340,867 0.09% 27,445 Up ×1
TAK Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) $311,800 0.09% 20,000 Up ×1
BBNX Beta Bionics, Inc. - Common Stock $250,342 0.07% 8,216 Up ×1
IHI $242,509 0.07% 3,902 Up ×1
BAC Bank of America Corporation Common Stock $241,560 0.07% 4,392 Up ×1
AMZN Amazon.com, Inc. - Common Stock $230,820 0.06% 1,000 Up ×1
ELAN Elanco Animal Health Incorporated Common Stock $205,299 0.06% 9,072 Up ×1
PLRX Pliant Therapeutics, Inc. - Common Stock $113,460 0.03% 93,000 Up ×1

Biggest new bets

New positions opened this quarter, largest first.

Security Value Shares % of portfolio
SPY $238,672,000 350,000 66.48%
QQQ $30,715,500 50,000 8.56%
AVDL $18,951,070 879,400 5.28%
AVDL $15,085,000 700,000 4.20%
MDWD $6,065,070 328,552 1.69%
AXGN $5,498,640 168,000 1.53%
EVTL $4,797,000 900,000 1.34%
OSUR $4,288,240 1,772,000 1.19%
OMER $3,794,445 218,700 1.06%
AUPH $3,586,294 224,846 1.00%
GLPG $2,943,000 90,000 0.82%
ANGO $2,737,218 213,789 0.76%
OMER $2,232,492 129,985 0.62%
LLY $2,149,360 2,000 0.60%
CERS $2,060,000 1,000,000 0.57%